High Dose Vitamin D Supplementation in Chronic Spontaneous Urticaria
Launched by SHIRAZ UNIVERSITY OF MEDICAL SCIENCES · Aug 16, 2016
Trial Information
Current as of May 29, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Uriticaria or angioedema daily or more than 3 days a weeks for at least 6 weeks
- Exclusion Criteria:
- • Physical urticaria aquired or hereditary angioedema Calcium level \> 10.3 mg/dl Glomerular filtration rate \<50 Sarcoidosis Primary hyperparathyroidism Granulomatous diseases Malignancies Pregnancy Lactation
About Shiraz University Of Medical Sciences
Shiraz University of Medical Sciences (SUMS) is a leading academic institution in Iran dedicated to advancing healthcare through innovative research and education. As a prominent clinical trial sponsor, SUMS plays a pivotal role in conducting rigorous clinical studies aimed at improving medical practices and patient outcomes. The university is committed to fostering collaboration among healthcare professionals, researchers, and industry partners to translate scientific discoveries into effective therapies. With a focus on ethical standards and regulatory compliance, SUMS strives to contribute to the global body of medical knowledge while enhancing the quality of care within the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shiraz, Fars, Iran, Islamic Republic Of
Patients applied
Trial Officials
Keramatallah Jahanshahi, MD
Principal Investigator
Shiraz University of Medical Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials